rs17024661

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000851.4(GSTM5):​c.567+502A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0362 in 413,860 control chromosomes in the GnomAD database, including 457 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.035 ( 117 hom., cov: 33)
Exomes 𝑓: 0.037 ( 340 hom. )

Consequence

GSTM5
NM_000851.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.21

Publications

5 publications found
Variant links:
Genes affected
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0916 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GSTM5NM_000851.4 linkc.567+502A>G intron_variant Intron 7 of 7 ENST00000256593.8 NP_000842.2 P46439Q5T8R2
GSTM5XM_005270784.5 linkc.567+502A>G intron_variant Intron 8 of 8 XP_005270841.1 P46439Q5T8R2
GSTM5XM_005270785.5 linkc.255+502A>G intron_variant Intron 4 of 4 XP_005270842.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GSTM5ENST00000256593.8 linkc.567+502A>G intron_variant Intron 7 of 7 1 NM_000851.4 ENSP00000256593.3 P46439

Frequencies

GnomAD3 genomes
AF:
0.0348
AC:
5297
AN:
152086
Hom.:
112
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0490
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0351
Gnomad ASJ
AF:
0.0404
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.0995
Gnomad FIN
AF:
0.0118
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0271
Gnomad OTH
AF:
0.0359
GnomAD4 exome
AF:
0.0370
AC:
9671
AN:
261656
Hom.:
340
Cov.:
4
AF XY:
0.0421
AC XY:
6023
AN XY:
142972
show subpopulations
African (AFR)
AF:
0.0486
AC:
368
AN:
7572
American (AMR)
AF:
0.0393
AC:
422
AN:
10732
Ashkenazi Jewish (ASJ)
AF:
0.0433
AC:
300
AN:
6936
East Asian (EAS)
AF:
0.000660
AC:
8
AN:
12124
South Asian (SAS)
AF:
0.0990
AC:
3927
AN:
39682
European-Finnish (FIN)
AF:
0.0162
AC:
174
AN:
10722
Middle Eastern (MID)
AF:
0.0682
AC:
72
AN:
1056
European-Non Finnish (NFE)
AF:
0.0247
AC:
3928
AN:
158872
Other (OTH)
AF:
0.0338
AC:
472
AN:
13960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
425
851
1276
1702
2127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0350
AC:
5320
AN:
152204
Hom.:
117
Cov.:
33
AF XY:
0.0340
AC XY:
2532
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.0495
AC:
2056
AN:
41526
American (AMR)
AF:
0.0350
AC:
536
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0404
AC:
140
AN:
3468
East Asian (EAS)
AF:
0.00271
AC:
14
AN:
5170
South Asian (SAS)
AF:
0.0990
AC:
475
AN:
4800
European-Finnish (FIN)
AF:
0.0118
AC:
125
AN:
10600
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0271
AC:
1842
AN:
68022
Other (OTH)
AF:
0.0355
AC:
75
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
258
516
774
1032
1290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0323
Hom.:
95
Bravo
AF:
0.0360
Asia WGS
AF:
0.0470
AC:
165
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.47
DANN
Benign
0.51
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17024661; hg19: chr1-110258364; API